AMN Stock Recent News
AMN LATEST HEADLINES
DALLAS, April 03, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2023 financial results and second quarter 2023 outlook on Thursday, May 4, 2023, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.
Despite AMN Healthcare's (AMN) robust results in the majority of its segments, it records a soft overall Q4 performance.
AMN Healthcare Services, Inc. (NYSE:AMN ) Q4 2022 Earnings Conference Call February 16, 2023 5:00 PM ET Company Participants Randle Reece - Senior Director, Investor Relations Cary Grace - Chief Executive Officer Jeff Knudson - Chief Financial Officer Kelly Rakowski - Group President and COO of Strategic Talent Solutions Landry Seedig - Group President and COO of Nursing and Allied Solutions James Taylor - President and Chief Operating Officer of Physician and Leadership Solutions Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Tobey Sommer - Truist Tim Mulrooney - William Blair Mark Marcon - Robert W.
AMN Healthcare (AMN) delivered earnings and revenue surprises of 14.29% and 5.82%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
AMN vs. DOCS: Which Stock Is the Better Value Option?
Here is how AMN Healthcare Services (AMN) and Sorrento Therapeutics (SRNE) have performed compared to their sector so far this year.
AMN Healthcare Services (AMN) closed the most recent trading day at $96.75, making no change from the previous trading session.
The Healthcare sector has been a strong-performing space in the last year relative to the volatile S&P 500. Amid ongoing labor market tightness in the area, one firm is in demand but also features uncertain earnings.
AMN vs. DOCS: Which Stock Is the Better Value Option?
AMN Healthcare (AMN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.